- Home
- AKRO vs MGEE Comparison
AKRO vs MGEE Comparison
Compare AKRO & MGEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- MGEE
- Stock Information
- Founded
- AKRO 2017
- MGEE 1855
- Country
- AKRO United States
- MGEE United States
- Employees
- AKRO N/A
- MGEE 717
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- MGEE Electric Utilities: Central
- Sector
- AKRO Health Care
- MGEE Energy
- Exchange
- AKRO Nasdaq
- MGEE Nasdaq
- Market Cap
- AKRO 3.7B
- MGEE 3.1B
- IPO Year
- AKRO 2019
- MGEE N/A
- Fundamental
- Price
- AKRO $46.50
- MGEE $83.68
- Analyst Decision
- AKRO Strong Buy
- MGEE Sell
- Analyst Count
- AKRO 8
- MGEE 2
- Target Price
- AKRO $80.38
- MGEE $79.00
- AVG Volume (30 Days)
- AKRO 1.2M
- MGEE 149.4K
- Earning Date
- AKRO 11-07-2025
- MGEE 11-05-2025
- Dividend Yield
- AKRO N/A
- MGEE 2.14%
- EPS Growth
- AKRO N/A
- MGEE 12.86
- EPS
- AKRO N/A
- MGEE 3.60
- Revenue
- AKRO N/A
- MGEE $701,317,000.00
- Revenue This Year
- AKRO N/A
- MGEE $10.77
- Revenue Next Year
- AKRO N/A
- MGEE $3.48
- P/E Ratio
- AKRO N/A
- MGEE $23.31
- Revenue Growth
- AKRO N/A
- MGEE 8.61
- 52 Week Low
- AKRO $21.34
- MGEE $81.14
- 52 Week High
- AKRO $58.40
- MGEE $109.22
- Technical
- Relative Strength Index (RSI)
- AKRO 47.87
- MGEE 47.31
- Support Level
- AKRO $45.20
- MGEE $82.36
- Resistance Level
- AKRO $47.40
- MGEE $84.44
- Average True Range (ATR)
- AKRO 1.46
- MGEE 1.35
- MACD
- AKRO 0.06
- MGEE 0.00
- Stochastic Oscillator
- AKRO 34.90
- MGEE 62.71
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About MGEE MGE Energy Inc
MGE Energy provides electric service to 161,000 customers and natural gas service to 173,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.